PXS vs. CHLL, STX, MXC, VLG, NSCI, GENI, SNG, OPTI, OBI, and ABDX
Should you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Chill Brands Group (CHLL), Shield Therapeutics (STX), Argent BioPharma (MXC), Venture Life Group (VLG), NetScientific (NSCI), GENinCode (GENI), Synairgen (SNG), OptiBiotix Health (OPTI), Ondine Biomedical (OBI), and Abingdon Health (ABDX). These companies are all part of the "medical" sector.
Chill Brands Group (LON:CHLL) and Provexis (LON:PXS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.
Chill Brands Group has a net margin of 0.00% compared to Chill Brands Group's net margin of -83.03%. Chill Brands Group's return on equity of -75.88% beat Provexis' return on equity.
Chill Brands Group has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Provexis has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.
In the previous week, Chill Brands Group had 3 more articles in the media than Provexis. MarketBeat recorded 3 mentions for Chill Brands Group and 0 mentions for Provexis. Chill Brands Group's average media sentiment score of 0.00 beat Provexis' score of -0.27 indicating that Provexis is being referred to more favorably in the news media.
Provexis has lower revenue, but higher earnings than Chill Brands Group.
Provexis received 55 more outperform votes than Chill Brands Group when rated by MarketBeat users. However, 66.67% of users gave Chill Brands Group an outperform vote while only 64.21% of users gave Provexis an outperform vote.
0.0% of Chill Brands Group shares are held by institutional investors. Comparatively, 6.6% of Provexis shares are held by institutional investors. 24.0% of Chill Brands Group shares are held by insiders. Comparatively, 21.9% of Provexis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Provexis beats Chill Brands Group on 8 of the 13 factors compared between the two stocks.
Get Provexis News Delivered to You Automatically
Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Provexis Competitors List
Related Companies and Tools
